Healthcare Equipment and Supplies
Company Overview of Keystone Heart, Ltd.
Keystone Heart, Ltd., a medical device company, focuses on the development and commercialization of procedural tools and accessories for use during transcatheter aortic valve implantation (TAVI) and other complex percutaneous structural heart procedures. It designs and develops an embolic deflection device to reduce the chance of stroke and embolic events during TAVI and other structural heart procedures. The company also designs and develops cerebral protection devices to reduce the incidence of brain injury (stroke and silent stroke) during complex catheter-based interventions. Keystone Heart, Ltd. was formerly known as SMT R&D Ltd. and changed its name to Keystone Heart, Ltd. in April 201...
20 Galgaley Haplada Street
Herzliya Pituach Industrial Park
Founded in 2004
Key Executives for Keystone Heart, Ltd.
Chief Executive Officer and President
Chief Financial Officer and Vice President
Chief Medical Officer and Vice President
Compensation as of Fiscal Year 2013.
Keystone Heart, Ltd. Key Developments
Keystone Heart, Ltd.'s TriGuard(TM) Cerebral Protection Device Receives CE Marking
Sep 9 13
Keystone Heart, Ltd. announced that its TriGuard(TM) Cerebral Protection Device has received CE Marking, enabling the company to commercially market the TriGuard in Europe and other territories. The CE marking recognizes the conformity of the TriGuard device with the relevant directive of the European Community. The CE marked TriGuard is the device designed to cover all three aortic cerebral branches to minimize the risk of cerebral damage during Transcatheter Aortic Valve Replacement (TAVR) and other cardiovascular procedures. It is the only system designed for placement via one of two femoral artery access ports. The TriGuard(TM) accommodates most anatomical variations of the aortic arch and uses a Nitinol(R) frame and mesh - flexible and atraumatic, yet robust and sturdy.
Keystone Heart, Ltd. Announces Management Changes
Apr 25 12
Keystone Heart, Ltd. announced the addition of three key executives to its management team, including a new CEO, CFO and Chief Medical Officer, plus two additions to its board of directors. Keystone Heart's new President and Chief Executive Officer, Mr. Shuki Porath, joined the company in November 2011 as VP and General Manager. Prior to Keystone Heart, he served as CEO at SeamVad Ltd. and was CEO at ES Vascular Ltd. Mr. Lior Buchman is Keystone Heart's newly appointed Vice President and Chief Financial Officer. With over 15 years of experience in corporate financing, M&A and business development, Mr. Buchman joins Keystone Heart, having spent the last four years as VP Finance and CFO at NiTi Surgical Solutions. M. Pauliina Margolis, M.D., Ph.D. has joined Keystone Heart as Vice President and Chief Medical Officer. Prior to Keystone Heart, Dr. Margolis served as CMO and VP Scientific Affairs at Volcano Corporation, specializing in enhancing diagnosis and treatment of coronary and peripheral vascular disease. Mr. Udi Arad of Arad Law and Mr. David Fuchs of B&P Management have also been added to Keystone Heart's Board, joining Nissim Darvish, David Bonita and Vince Burgess of OrbiMed Advisors, LLC on the Board of Directors.
SMT Research & Development, Ltd. has Changed its Name to Keystone Heart, Ltd
Apr 25 12
SMT Research & Development, Ltd. changed its name to Keystone Heart, Ltd.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|